Department of Innovative Research & Education for Clinicians & Trainees (DiRECT)

英文原著 2020年度実績

  1. Kurita N#, Wakita T, Ishibashi Y, Fujimoto S, Yazawa M, Suzuki T, Koitabashi K, Yanagi M, Kawarazaki H, Green J, Fukuhara S, Shibagaki Y. (#corresponding author)
    Association between health-related hope and adherence to prescribed treatment in CKD patients: multicenter cross-sectional study.
    BMC Nephrology 2020; 21: 453
  2. Iida H, Fujimoto S, Wakita T, Yanagi M, Suzuki T, Koitabashi K, Yazawa M, Kawarazaki H, Ishibashi Y, Shibagaki Y, Kurita N#. (#corresponding author).
    Psychological Flexibility and Depression in Advanced CKD and Dialysis.
    Kidney Medicine 2020; 2: 684-691.e1.
  3. Yazawa M, Omae K, Shibagaki Y, Inaba M, Tsuruya K, Kurita N.
    The effect of transportation modality to dialysis facilities on health-related quality of life among hemodialysis patients; from the Japanese Dialysis Outcomes and Practice Pattern Study (J-DOPPS).
    Clinical Kidney Journal 2020; 13: 640-646.
  4. Wada O, Kurita N#, Kamitani T, Mizuno K. (#corresponding author)
    Implications of evaluating leg muscle mass and fat mass separately for quadriceps strength in knee osteoarthritis: the SPSS-OK study.
    Clinical Rheumatology 2020; 39: 1655-1661.
  5. Wada O, Kurita N#, Yamada M, Mizuno K. (#corresponding author)
    Structural severity, phase angle, and quadriceps strength among patients with knee osteoarthritis: the SPSS-OK study.
    Clinical Rheumatology  2020 ;39: 3049-3056.
  6. Honda H, Kimachi M, Kurita N, Joki N, Nangaku M.
    Low rather than high mean corpuscular volume is associated with mortality in Japanese patients under hemodialysis.
    Scientific Reports 2020; 10: 15663.
  7. Hasegawa J, Kimachi M, Kurita N, Kanda E, Wakai S, Nitta K
    Normalized Protein Catabolic Rate and Mortality Risk of Patients on Hemodialysis by Frailty Status: The Japanese Dialysis Outcomes and Practice Pattern Study
    Journal of Renal Nutrition 2020;30:535-539
  8. Tsujimoto Y, Fujii T, Onishi A, Omae K, Luo Y, Imai H, Takahashi S, Itaya T, Pinson C, Nevitt SJ, Furukawa TA
    No consistent evidence of data availability bias existed in recent individual participant data meta-analyses: a meta-epidemiological study
    J Clin Epidemiol 2020; 118: 107-114.e5
  9. Hayashi N, Kanda M, Omae K, Kodera Y.
    The efficacy of oxaliplatin combination adjuvant chemotherapy for elderly patients with stage III colorectal cancer.
    Nagoya J Med Sci 2020;82(4):603-611.
  10. Nakamura S, Kanda M, Shimizu D, Tanaka C, Inokawa Y, Hattori N, Hayashi M, Yamada S, Nakayama G, Omae K, Koike M, Kodera Y.
    AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer.
    Anticancer Res 2020;40(12):6713-6721.
  11. Nakamura S, Kanda M, Shimizu D, Sawaki K, Tanaka C, Hattori N, Hayashi M, Yamada S, Nakayama G, Omae K, Koike M, Kodera Y.
    STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer.
    Cancer Genomics Proteomics 2020;17(5):509-516.
  12. Yoshioka T, Omae K, Kawada T, Inoue Y, Sugimoto M, Oeda T, Uehara S, Araki M, Fukuhara S.
    Preoperative Use of Alpha-1 Receptor Blockers in Male Patients Undergoing Extracorporeal Shock Wave Lithotripsy for a Ureteral Calculus.
    Acta Med Okayama     2020;74(4):293-299.
  13. Kanda M, Koike M, Iwata N, Shimizu D, Tanaka C, Hattori N, Hayashi M, Yamada S, Omae K, Nakayama G, Kodera Y.
    An Open-Label Single-Arm Phase II Study of Treatment with Neoadjuvant S-1 Plus Cisplatin for Clinical Stage III Squamous Cell Carcinoma of the Esophagus.
    Oncologist     2020; 25: e1650-e1654.
  14. Kanda M, Koike M, Shimizu D, Tanaka C, Hattori N, Hayashi M, Yamada S, Omae K, Kodera Y.
    Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus.
    Ann Surg Oncol 2020; 27(9): 3195-3205.
  15. Takagi T, Fukuda H, Ishihara H, Yoshida K, Kondo T, Kobayashi H, Iizuka J, Okumi M, Ishida H, Omae K, Tanabe K.
    Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era.
    Urol Oncol 2020; 38(5): 515-520.
  16. Nakamura S, Kanda M, Koike M, Shimizu D, Umeda S, Hattori N, Hayashi M, Tanaka C, Kobayashi D, Yamada S, Omae K, Kodera Y.
    KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma.
    Ann Surg Oncol 2020; 27(7): 2559-2568.
  17. Kanda M, Koike M, Shimizu D, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Omae K, Yamada S, Nakayama G, Kodera Y.
    Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
    Ann Surg Oncol 2020; 27(4): 1233-1240.

研究実績

PAGETOP